The Plain Record

Neutral daily news — clear headlines, complete facts.

Legal

Tylenol Maker and Retailers Urge Appeals Court to Reconsider Autism Lawsuits

Kenvue and major retailers asked the 2nd U.S. Circuit Court of Appeals to revisit a ruling that revived 500 lawsuits alleging a link between Tylenol and autism.

Published September 11, 2026 at 12:51 PM EDT

The short answer

Kenvue and major retailers asked the 2nd U.S. Circuit Court of Appeals to revisit a ruling that revived 500 lawsuits alleging a link between Tylenol and autism.

Tylenol Maker and Retailers Urge Appeals Court to Reconsider Autism Lawsuits

The Facts

Who
Tylenol maker Kenvue and retailers including Albertsons, Costco, CVS, Dollar General, Dollar Tree, Family Dollar, Kroger, Safeway, 7-Eleven, Target, Walgreens, and Walmart.
What
Tylenol maker Kenvue and retailers including Albertsons, Costco, CVS, Dollar General, Dollar Tree, Family Dollar, Kroger, Safeway, 7-Eleven, Target, Walgreens, and Walmart filed a legal petition asking a federal appeals court to reconsider its decision to allow more than 500 lawsuits linking Tylenol to autism and ADHD to proceed to trial.
When
Thursday, September 10, 2026
Where
Manhattan, New York
Why
The defendants argue that the appeals court incorrectly applied evidence rules by allowing what they describe as unsettled scientific theories to be decided by a jury rather than a judge.

The manufacturer of Tylenol and several major U.S. retailers petitioned a federal appeals court on Thursday, September 10, 2026, to reconsider a decision that allowed more than 500 lawsuits to proceed. The legal actions involve allegations that the use of acetaminophen, the active ingredient in Tylenol, during pregnancy is linked to autism and attention deficit hyperactivity disorder (ADHD) in children.

The request follows a July 13 ruling by the 2nd U.S. Circuit Court of Appeals in Manhattan that revived the private lawsuits. Those cases had previously been dismissed by a district judge who determined that the scientific testimony provided by the plaintiffs was not reliable enough for a trial.

In the Thursday filing, Kenvue—the maker of Tylenol—and retailers including Walmart, CVS, and Walgreens argued that the appeals court failed to respect the role of district judges as "gatekeepers" of evidence. The companies stated that lay juries lack the specialized knowledge required to resolve complex scientific questions and argued that the plaintiffs' theories should not be presented at trial.

U.S. District Judge Denise Cote had originally excluded testimony from three experts: Andrea Baccarelli of Harvard, Eric Hollander of the Albert Einstein College of Medicine, and Brandon Pearson, formerly of Columbia University. The defendants have asked the appeals court to either reverse its revival of the suits or instruct Judge Cote to re-evaluate whether the experts' opinions are admissible.

While Donald Trump and top U.S. health officials suggested a possible link to autism in September 2025, medical societies generally consider acetaminophen the preferred treatment for pain and fever during pregnancy. There is no firm scientific evidence of a link. Kenvue, based in New Jersey, was spun off from Johnson & Johnson in 2023.

The litigation involves hundreds of families who have filed suit seeking damages for developmental disorders they attribute to prenatal acetaminophen exposure. With more than 500 private lawsuits currently revived, the outcome of this appeal will determine whether these parents and guardians can present their claims to a jury or if the cases will be dismissed for a second time. The named retailers include national chains like Target, Costco, Kroger, Dollar General, and 7-Eleven.

Acetaminophen is currently recommended by many doctors as the standard treatment for fever and pain during pregnancy. The defendants argue that allowing "unsettled scientific questions" to reach a jury undermines the established role of judges in vetting evidence. The 2nd U.S. Circuit Court of Appeals rarely reconsiders its own decisions. No specific date for a new ruling has been reported.

Timeline of what happened

Key dates and decisions, in the order they occurred.

  1. December 19, 2023

    District Judge excludes expert testimony and dismisses lawsuits

  2. September 11, 2025

    U.S. health officials suggest a link between Tylenol and autism

  3. July 13, 2026

    Appeals court reverses dismissal and revives 500 lawsuits

  4. September 10, 2026

    Defendants file petition for appeals court to revisit its decision

Summaries are written by The Plain Record to state the facts of a story plainly and without political slant. Drafted with AI assistance and checked against the source record before publication. See how we report, or report a correction.

← Back to the front page

Questions readers ask

What happened: Tylenol Maker and Retailers Urge Appeals Court to Reconsider Autism Lawsuits?

Tylenol maker Kenvue and retailers including Albertsons, Costco, CVS, Dollar General, Dollar Tree, Family Dollar, Kroger, Safeway, 7-Eleven, Target, Walgreens, and Walmart filed a legal petition asking a federal appeals court to reconsider its decision to allow more than 500 lawsuits linking Tylenol to autism and ADHD to proceed to trial.

Who is involved?

Tylenol maker Kenvue and retailers including Albertsons, Costco, CVS, Dollar General, Dollar Tree, Family Dollar, Kroger, Safeway, 7-Eleven, Target, Walgreens, and Walmart.

When did this happen?

Thursday, September 10, 2026

Where did this happen?

Manhattan, New York

Why does this matter?

The defendants argue that the appeals court incorrectly applied evidence rules by allowing what they describe as unsettled scientific theories to be decided by a jury rather than a judge.